Madison Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.32M Buy
1,140
+66
+6% +$77.9K 0.14% 84
2026
Q2
$1.29M Buy
1,074
+226
+27% +$231K 0.16% 68
2026
Q1
$780K Buy
848
+77
+10% +$78.1K 0.12% 82
2025
Q4
$829K Sell
771
-19
-2% -$18.2K 0.15% 66
2025
Q3
$603K Buy
790
+9
+1% +$6.7K 0.12% 80
2025
Q2
$609K Sell
781
-86
-10% -$66.8K 0.13% 78
2025
Q1
$716K Sell
867
-23
-3% -$19.1K 0.18% 66
2024
Q4
$687K Sell
890
-4
-0.4% -$3.31K 0.19% 65
2024
Q3
$792K Buy
894
+284
+47% +$255K 0.23% 56
2024
Q2
$552K Buy
610
+10
+2% +$8K 0.19% 64
2024
Q1
$466K Buy
600
+46
+8% +$32.7K 0.17% 68
2023
Q4
$323K Buy
+554
New +$323K 0.13% 87

Other funds holding LLY

Madison Wealth Partners's LLY Position: Q3 2026 in Review

Madison Wealth Partners increased its Eli Lilly (LLY) stake by 6.1% in Q3 2026, buying an estimated $77.9K and bringing the position to 1,140 shares worth $1.32M. The position accounts for 0.14% of the portfolio, ranked #84.

Madison Wealth Partners first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Madison Wealth Partners held 1,140 shares of Eli Lilly worth $1.32M as of Q3 2026.
  • Madison Wealth Partners bought 66 Eli Lilly shares in Q3 2026, an estimated $77.9K.
  • Eli Lilly made up 0.14% of Madison Wealth Partners's portfolio in Q3 2026, its #84 holding.
  • Madison Wealth Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Madison Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.